DT
GILD icon

Diversified Trust’s Gilead Sciences GILD Stock Holding History

Diversified Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.03M Buy
55,634
+15,148
+37% +$2M 0.11% 100
2026
Q1 		$5.64M Sell
40,486
-6,384
-14% -$894K 0.1% 111
2025
Q4 		$5.75M Buy
46,870
+3,641
+8% +$442K 0.11% 112
2025
Q3 		$4.8M Buy
43,229
+8,422
+24% +$957K 0.1% 117
2025
Q2 		$3.86M Sell
34,807
-31
-0.1% -$3.3K 0.09% 131
2025
Q1 		$3.9M Buy
34,838
+383
+1% +$39.5K 0.1% 123
2024
Q4 		$3.18M Buy
34,455
+1,019
+3% +$91.7K 0.08% 151
2024
Q3 		$2.8M Buy
33,436
+449
+1% +$34.3K 0.07% 169
2024
Q2 		$2.26M Buy
32,987
+3,483
+12% +$232K 0.06% 182
2024
Q1 		$2.16M Sell
29,504
-3,201
-10% -$246K 0.07% 177
2023
Q4 		$2.65M Sell
32,705
-4,860
-13% -$378K 0.09% 127
2023
Q3 		$2.82M Sell
37,565
-5,393
-13% -$415K 0.11% 109
2023
Q2 		$3.31M Sell
42,958
-105
-0.2% -$8.37K 0.12% 100
2023
Q1 		$3.57M Buy
43,063
+1,763
+4% +$146K 0.14% 90
2022
Q4 		$3.55M Buy
41,300
+5,992
+17% +$475K 0.15% 84
2022
Q3 		$2.18M Buy
35,308
+632
+2% +$39.9K 0.1% 106
2022
Q2 		$2.14M Sell
34,676
-853
-2% -$52.8K 0.09% 122
2022
Q1 		$2.11M Buy
35,529
+1,982
+6% +$127K 0.07% 137
2021
Q4 		$2.44M Buy
33,547
+2,723
+9% +$188K 0.08% 127
2021
Q3 		$2.15M Sell
30,824
-2,209
-7% -$155K 0.08% 132
2021
Q2 		$2.27M Buy
33,033
+1,311
+4% +$87.5K 0.08% 123
2021
Q1 		$2.05M Sell
31,722
-1,161
-4% -$74.9K 0.08% 126
2020
Q4 		$1.92M Sell
32,883
-628
-2% -$37.9K 0.08% 126
2020
Q3 		$2.12M Buy
33,511
+3,684
+12% +$255K 0.1% 113
2020
Q2 		$2.29M Buy
29,827
+32
+0.1% +$2.45K 0.12% 93
2020
Q1 		$2.23M Buy
29,795
+591
+2% +$40.8K 0.13% 86
2019
Q4 		$1.9M Buy
29,204
+7,282
+33% +$474K 0.09% 98
2019
Q3 		$1.39M Sell
21,922
-2,115
-9% -$138K 0.07% 101
2019
Q2 		$1.62M Sell
24,037
-128
-0.5% -$8.42K 0.08% 93
2019
Q1 		$1.57M Buy
24,165
+1,031
+4% +$68.5K 0.08% 92
2018
Q4 		$1.45M Buy
+23,134
New +$1.62M 0.08% 89

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Diversified Trust's GILD Position: Q2 2026 in Review

Diversified Trust increased its Gilead Sciences (GILD) stake by 37% in Q2 2026, buying an estimated $2M and bringing the position to 55,634 shares worth $7.03M. The position accounts for 0.11% of the portfolio, ranked #100.

Diversified Trust first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Diversified Trust held 55,634 shares of Gilead Sciences worth $7.03M as of Q2 2026.
  • Diversified Trust bought 15,148 Gilead Sciences shares in Q2 2026, an estimated $2M.
  • Gilead Sciences made up 0.11% of Diversified Trust's portfolio in Q2 2026, its #100 holding.
  • Diversified Trust first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.